BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15812516)

  • 21. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias.
    Chelu MG; Wehrens XH
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):952-6. PubMed ID: 17956253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.
    Maier LS; Bers DM
    Cardiovasc Res; 2007 Mar; 73(4):631-40. PubMed ID: 17157285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase A-dependent phosphorylation of ryanodine receptors increases Ca2+ leak in mouse heart.
    Morimoto S; O-Uchi J; Kawai M; Hoshina T; Kusakari Y; Komukai K; Sasaki H; Hongo K; Kurihara S
    Biochem Biophys Res Commun; 2009 Dec; 390(1):87-92. PubMed ID: 19781523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
    Vila-Petroff M; Salas MA; Said M; Valverde CA; Sapia L; Portiansky E; Hajjar RJ; Kranias EG; Mundiña-Weilenmann C; Mattiazzi A
    Cardiovasc Res; 2007 Mar; 73(4):689-98. PubMed ID: 17217936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.
    Guo T; Zhang T; Mestril R; Bers DM
    Circ Res; 2006 Aug; 99(4):398-406. PubMed ID: 16840718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
    Yuan Q; Fan GC; Dong M; Altschafl B; Diwan A; Ren X; Hahn HH; Zhao W; Waggoner JR; Jones LR; Jones WK; Bers DM; Dorn GW; Wang HS; Valdivia HH; Chu G; Kranias EG
    Circulation; 2007 Jan; 115(3):300-9. PubMed ID: 17224479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice.
    Kerfant BG; Gidrewicz D; Sun H; Oudit GY; Penninger JM; Backx PH
    Circ Res; 2005 May; 96(10):1079-86. PubMed ID: 15860757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of treatment with inderal and visken of patients with circulatory insufficiency].
    Shevchenko IA; Marchenko AM; Simonenko VB
    Voen Med Zh; 1983 Feb; (2):51-3. PubMed ID: 6133395
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta-blockers in the therapy of myocardial infarct].
    Rossi P
    G Ital Cardiol; 1983; 13(6):462-71. PubMed ID: 6139322
    [No Abstract]   [Full Text] [Related]  

  • 32. [Beta-blockers and cardiac insufficiency: a cultural revolution?].
    Komajda M
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1449-51. PubMed ID: 9891826
    [No Abstract]   [Full Text] [Related]  

  • 33. Diastolic release of calcium from the sarcoplasmic reticulum: a potential target for treating triggered arrhythmias and heart failure.
    Shannon TR; Lew WY
    J Am Coll Cardiol; 2009 May; 53(21):2006-8. PubMed ID: 19460615
    [No Abstract]   [Full Text] [Related]  

  • 34. Does Ca2+/calmodulin-dependent protein kinase deltac activate or inhibit the cardiac ryanodine receptor ion channel?
    Yamaguchi N; Meissner G
    Circ Res; 2007 Feb; 100(3):293-5. PubMed ID: 17307966
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta blockers and heart failure.
    Harv Heart Lett; 2004 Oct; 15(2):7. PubMed ID: 15496369
    [No Abstract]   [Full Text] [Related]  

  • 36. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dispelling the myth: incorporating beta-blockers into practice guidelines.
    Packer M
    Am J Manag Care; 2000 Apr; 6(6 Suppl):S313-6. PubMed ID: 11010427
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiodynamic effects and mechanisms of action of beta-blockers.
    Greenberg BH
    Am J Manag Care; 2000 Apr; 6(6 Suppl):S303-7. PubMed ID: 11010425
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sepsis-induced myocardial depression and calcium mishandling: an acceptable unifying theory?
    Fernandes CJ; Campos AH
    Crit Care Med; 2008 Sep; 36(9):2695-6. PubMed ID: 18728488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.